Dr. Andrei Horia Iagaru, MD is a Nuclear Medicine Specialist - General practicing in Stanford, CA
He has not yet shared a personalized biography with Doctor.com.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Carol Davila University of Medicine & Pharmacy | Other Degree | MD | Not Specified |
| Universitatea de Medicina si Farmacie Carol Davila | Medical Degree | 2000 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Stanford University Program | Not Specified |
| Certification | Cert. Body | Year |
|---|---|---|
| Nuclear Medicine | Nuclear Medicine | Not Specified |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | Nuclear medicine communications | 18F-FDG PET/CT in the magement of patients with post-transplant lymphoproliferative disorder. | 2014 |
| Other Publication | Methods in molecular biology (Clifton, N.J.) | The Clinical Use of PET/CT in the Evaluation of Melanoma. | 2014 |
| Other Publication | Jourl of nuclear medicine : official publication, Society of Nuclear M | Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin | 2013 |
| Other Publication | Cardiovascular and interventiol radiology | Root cause alysis of gastroduodel ulceration after yttrium-90 radioembolization. | 2013 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc | 2013 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Combined F-18-fluoride and F-18-FDG PET | 2013 |
| Other Publication | Cardiovascular and interventiol radiology | Safety of repeated yttrium-90 radioembolization. | 2013 |
| Other Publication | AMERICAN JOURL OF ROENTGENOLOGY | Imaging Tumor Angiogenesis: The Road to Clinical Utility | 2013 |
| Other Publication | PLOS ONE | An Observatiol Study of Circulating Tumor Cells | 2013 |
| Other Publication | Clinical nuclear medicine | Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F F PET/CT | 2013 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Second Sino-American Conference on Nuclear Medicine | 2013 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Combined F-18-Fluoride and F-18-FDG PET | 2013 |
| Other Publication | Clinical nuclear medicine | 18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis. | |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Initial investigation of F-18-F PET | 2012 |
| Other Publication | Keu, K., ir, V. S., Mittra, E., Gambhir, S. S., Iagaru, A. | The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmory Nodules by FDG PET | 2012 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | Positron Emission Tomography of Cu-64 | 2012 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer | 2012 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer | 2012 |
| Other Publication | INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes | 2012 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 F PET/CT | 2012 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on F-18-FDG PET/CT | 2012 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Prospective comparison of combined F-18-FDG | 2012 |
| Other Publication | HUMAN GENE THERAPY | Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [F | 2012 |
| Other Publication | RADIOTHERAPY AND ONCOLOGY | Correlation between metabolic tumor volume | 2011 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | PET/CT Imaging of Thyroid Cancer | 2011 |
| Other Publication | RADIOLOGY | Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2 | 2011 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning? | 2011 |
| Other Publication | SEMIRS IN NUCLEAR MEDICINE | Thyroid Stunning: Fact or Fiction? | 2011 |
| Other Publication | RADIOLOGY | Case 166: Metastatic Left Pulmory Artery Sarcoma | 2011 |
| Other Publication | American jourl of nuclear medicine and molecular imaging | (18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge. | 2011 |
| Other Publication | Current drug discovery technologies | Current concepts and future directions in radioimmunotherapy. | 2010 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18 FDG PET/CT Demonstration of Lymphohistiocytic Meningitis | 2010 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory | 2010 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Combined F-18-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? REPLY | 2010 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma | 2009 |
| Other Publication | Mittra, E., Quon, A., Gambhir, S. S., Iagaru, A. | Efficacy of F-18-FDG PET/CT for Breast Cancer | 2009 |
| Other Publication | HELLENIC JOURL OF NUCLEAR MEDICINE | Evaluation by F-18-FDG-PET of patients with al squamous cell carcinoma | 2009 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Tumor Metabolic Phenotypes on F-18 FDG PET REPLY | 2009 |
| Other Publication | JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY | Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization | 2009 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET | 2009 |
| Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-FDG PET/CT evaluation of patients with ovarian carcinoma | 2008 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Y-90-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma | 2008 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Rhabdomyosarcoma diffusely metastatic to the bone marrow | 2008 |
| Other Publication | HELLENIC JOURL OF NUCLEAR MEDICINE | F-18-FDG-PET/CT evaluation of response to treatment in lymphoma | 2008 |
| Other Publication | RADIOLOGIC CLINICS OF NORTH AMERICA | Perspectives of molecular imaging and radioimmunotherapy in lymphoma | 2008 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma | 2008 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas | 2008 |
| Other Publication | TURE CLINICAL PRACTICE ONCOLOGY | Molecular imaging can accelerate anti-angiogenic drug development and testing | 2007 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18 FDG PET/CT in the magement of thyroid cancer | 2007 |
| Other Publication | SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | Advances in metabolic imaging for surgical oncology | 2007 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET | 2007 |
| Other Publication | JOURL OF NUCLEAR MEDICINE | Treatment of thyrotoxicosis | 2007 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18 FDG PET visualization of uriry leak after nephrostomy tube removal | 2007 |
| Other Publication | REVISTA ESPANOLA DE MEDICI NUCLEAR | Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET | 2007 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography | 2007 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET/CT demonstration of an adrel metastasis in a patient with aplastic thyroid cancer | 2007 |
| Other Publication | ANLS OF NUCLEAR MEDICINE | Breast MRI and F-18 FDG PET/CT in the magement of breast cancer | 2007 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas | 2006 |
| Other Publication | NUCLEAR MEDICINE COMMUNICATIONS | F-18-FDG PET and PET/CT for detection of pulmory metastases from musculoskeletal sarcomas | 2006 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | 2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography and positron emission tomography | 2006 |
| Other Publication | JOURL OF NUCLEAR CARDIOLOGY | Demonstration of an ectopic mediastil parathyroid adenoma on Tc | 2006 |
| Other Publication | AMERICAN JOURL OF ROENTGENOLOGY | PET/CT follow-up in nonossifying fibroma | 2006 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET imaging of uriry bladder oat cell carcinoma with widespread osseous metastases | 2006 |
| Other Publication | MOLECULAR IMAGING AND BIOLOGY | Merkel cell carcinoma | 2006 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | F-18FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation | 2006 |
| Other Publication | EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | Demonstration of a right inguil hernia containing uriry bladder diverticulum on whole | 2006 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | Failed atrial septal defect repair versus pulmory hypertension with right ventricular failure | 2005 |
| Other Publication | CLINICAL NUCLEAR MEDICINE | FDG PET-CT demonstration of Sjogren's sialoadenitis | 2005 |
Dr. Andrei Horia Iagaru, MD has not yet indicated the hospitals that he is affiliated with.
Years In Practice: 17 (started in 2007)
Accepts New Patients: Yes
Dr. Andrei Horia Iagaru, MD has not yet listed the medications that he commonly prescribes.
Dr. Andrei Horia Iagaru, MD has not yet added any information about his practice's billing policies and payment options.
